Cargando…
Breast cancer genome heterogeneity: a challenge to personalised medicine?
Implementation of high-throughput genomics sequencing approaches into routine laboratory practice has raised the potential for the identification of multiple breast cancer targets suitable for future therapeutic intervention in order to improve cancer outcomes. Results from these studies have reveal...
Autores principales: | Swanton, Charles, Burrell, Rebecca A, Futreal, P Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109569/ https://www.ncbi.nlm.nih.gov/pubmed/21345264 http://dx.doi.org/10.1186/bcr2807 |
Ejemplares similares
-
Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity
por: Fisher, Rosalie, et al.
Publicado: (2011) -
Personalised medicine: are we ready?
por: Louis, Renaud, et al.
Publicado: (2017) -
The somatic genetic architecture of human cancer: heterogeneity and the challenges for translational medicine
por: Futreal, Andy
Publicado: (2012) -
Promoting predictive, preventive and personalised medicine: European event of global importance
por: Golubnitschaja, Olga, et al.
Publicado: (2011) -
Special Issue: Present and Future of Personalised Medicine for Endocrine Cancers
por: Ronchi, Cristina L., et al.
Publicado: (2022)